Skip to content
Global CDMO partner, since 2005

Trusted manufacturingfor globalpharma brands

Manufacturing trust for 500+ pharma companies across 80+ countries. From concept and formulation to globally accredited, regulated-market supply.

Corporate filmConcept · Scale · Supply
80+
Countries supplied
500+
Pharma partners
30+
Accreditations
1,000+
Formulations
Partners

The companies that trust us with their products

A manufacturing partner to global majors and India's largest pharma houses — across regulated markets, dosage forms and brand families.

Sun Pharma
Abbott
Cipla
Sanofi
GSK
Lupin
Glenmark
Torrent Pharma
Mankind Pharma
Alkem Laboratories
Lincoln Pharmaceuticals
Zydus
Intas Pharmaceuticals
IPCA Laboratories
Macleods Pharmaceuticals
Sun Pharma
Abbott
Cipla
Sanofi
GSK
Lupin
Glenmark
Torrent Pharma
Mankind Pharma
Alkem Laboratories
Lincoln Pharmaceuticals
Zydus
Intas Pharmaceuticals
IPCA Laboratories
Macleods Pharmaceuticals
Hetero Drugs
USV
Zuventus Healthcare
Troikaa Pharmaceuticals
Hegde & Hegde
MedPlus
Eris Lifesciences
MSN Laboratories
Ajanta Pharma
Dr. Morepen
Leeford Healthcare
TATA 1mg
Medika Bazaar
ESIC
Janaushadhi
Hetero Drugs
USV
Zuventus Healthcare
Troikaa Pharmaceuticals
Hegde & Hegde
MedPlus
Eris Lifesciences
MSN Laboratories
Ajanta Pharma
Dr. Morepen
Leeford Healthcare
TATA 1mg
Medika Bazaar
ESIC
Janaushadhi
Global majorsTop Indian pharmaBrand owners & distributors
Scale & reach

Two decades of measurable manufacturing trust

A vertically integrated CDMO delivering across dosage forms, geographies and regulatory regimes since 2005.

01Products1000+Developed and manufactured across regulated markets.
02Countries80+Supplied across six continents.
03Partners500+Pharma companies, brand owners and distributors.
04Accreditations30+WHO-GMP, PIC/S, ISO, Health Canada, AYUSH and more.
05Manufacturing10Manufacturing blocks across two factories in Himachal Pradesh.
06People1200+Employees, scientists and specialists.
Flagship capability

Pioneer in Nasal Spray and DPI

Among India's earliest manufacturers to industrialise metered nasal-spray and DPI production. Aqueous, suspension and powder platforms, validated for global filings, exported to 80+ countries.

  • Trusted to manufacture Allegra Nasal for Sanofi.

  • 10+ innovative formulations under development, first time in India.

Nasal sprayBiodeal Midazolam Nasal Spray 1.25% w/v carton and bottle
Nasal sprayBiodeal Flixsone OZ fluticasone furoate and oxymetazoline nasal spray carton and bottle
DPIBiodeal glycopyrrolate, formoterol fumarate and budesonide powder for inhalation carton with inhaler device
DPIBiodeal formoterol fumarate and budesonide powder for inhalation carton with inhaler device
Capabilities

A full-service partner, built with a manufacturer's precision

Four engagement models, one quality system, engineered for pharma companies that need scale without compromise.

01

Contract Manufacturing

End-to-end CDMO across solids, semi-solids and sterile dosage forms. 500+ partners.

02

Loan Licensing

P2P arrangements under partner brand and registrations. 10+ active licensees.

03

Research & Development

DSIR-approved labs. 35 R&D scientists. Formulation, analytical, regulatory.

04

Nasal & DPI Systems

Dedicated platform. Aqueous, suspension and powder lines.

Manufacturing footprint

Two factories. Ten manufacturing blocks.

Eco-friendly, pollution-free belt. WHO-GMP and PIC/S certified. Built for scale and for the regulators of tomorrow's markets.

Geographic footprint, North India

Two manufacturing factories in Himachal Pradesh, supported by the corporate office in Noida.

Manufacturing
Corporate
Linked
N0  100 KMUNIT INALAGARHUNIT IIPAONTA SAHIBNOIDACORPORATE31.0°N · 77.1°E
Unit I · Nalagarh, HP

Where 3 billion tablets are made each year

Seven manufacturing blocks on a 5.5-acre site. WHO-GMP and PIC/S certified. Specialised laser-coding line under PLC control. Full 24/7×4 surveillance on packaging.

Tablets / yr
3 B
Capsules / yr
650 M
Tubes / yr
21 M
Site
5.5 ac
Unit II · Paonta Sahib, HP

Sterile core. Grade A and B.

Three manufacturing blocks on 14 acres. Eight injectable lines under dedicated WFI and pure-steam utilities.

Site
14 ac
Built-up
57,661 m²
Inj. lines
8
Grade
A / B
1,200+ people, 80+ countries served.
See full manufacturing capabilities
Credentials

A wall of credentials, a single open file

30+ accreditations across pharma, quality, lab, food and trade — every one a real audit on a real schedule.

Our story

20+ years of disciplined manufacturing habit

See full story
Since 2005

Biodeal began in 2005 with one tablet line in Nalagarh, a small team, and an unfashionable belief that quality is a habit, not a department— twenty years on, that habit has shipped to eighty countries, kept faith with more than five hundred partners, and built one of India's most respected contract manufacturing organisations.

Milestones2005 to 2026
  • 2005Incorporated, Unit I Nalagarh
  • 2008WHO-GMP certified
  • 2011Nasal-spray platform commissioned
  • 2017Unit II Paonta Sahib, sterile lines
  • 2024Health Canada audit cleared
  • 2024Piramal strategic financing
  • 2026Injectable CDMO capability established; 8-line Grade A/B sterile facility acquired
Investor preview

Building India's next-generation pharmaceutical CDMO

Backed by Piramal Alternatives' strategic investment, Biodeal is scaling capacity and export reach for the next phase of growth.

40–45%
Annual growth · 5-yr CAGR
Piramal
2024 strategic deal
Enquire

Tell us what you need to make

A focused brief gets you a routed answer from the right team within one working day.